Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
Two hundred patients with rheumatoid arthritis were studied in a prospective open trial comparing treatment with sulphasalazine and auranofin in patients with active disease over 12 months. The two drugs improved many parameters of disease activity at 12, 24, and 48 weeks. At 12 weeks, the group tre...
Gardado en:
| Publicado en: | Ann Rheum Dis |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
1992
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004691/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1350192/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.51.4.461 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|